Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial

By sjmartinez • May 6, 2024

Frantz RP, McLaughlin VV, Sahay S, Escribano Subías P, Zolty RL, Benza RL, Channick RN, Chin KM, Hemnes AR, Howard LS, Sitbon O, Vachiéry JL, Zamanian RT, Cravets M, Roscigno RF, Mottola D, Osterhout R, Bruey JM, Elman E, Tompkins CA, Parsley E, Aranda R, Zisman LS, Ghofrani HA; TORREY Study Investigators. Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Respir Med. 2024 May 2:S2213-2600(24)00072-9. doi: 10.1016/S2213-2600(24)00072-9. Epub ahead of print. PMID: 38705167.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

What Is the Role of Sentinel Lymph Node Biopsy in Recurrent Head and Neck Melanoma?

Wooten C, Pillutla P, St John MA. What Is the Role of Sentinel Lymph Node Biopsy in Recurrent Head and Neck Melanoma? Laryngoscope. 2025 Jul[...]

Successful Treatment of Post-coronavirus Disease 2019 (COVID-19) Autoimmune Encephalitis With Plasmapheresis After a Failed Trial of Steroids

Kamel T, Toppen W, Salahmand Y. Successful Treatment of Post-coronavirus Disease 2019 (COVID-19) Autoimmune Encephalitis With Plasmapheresis After a Failed Trial of Steroids. Cureus. 2025[...]

Nursing Recommendations to Improve Discharge and Care Transitions From the Bedside

Emmanouilidou E, Krishnan D, Kaplan E, Moritz V, Kaloti I, Sengupta S, Czypinski L, Dowling E, Simon W, Dermenchyan A. Nursing Recommendations to Improve Discharge[...]